CG
Cognetivity Neurosciences Ltd.
CGNSF · OTC
$0.00 +0.00% (+$0.00)
Market Cap $12.7K
P/E Ratio -
Div. Yield -
ROE -
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.28x
P/E N/A
P/FFO N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
0 /100
Weak Gross margin 4,694.86%
FCF margin 13,252.30%
Net margin 16,386.30%
Quality
57 /100
Average ROIC 97.17%
Asset turnover 0.02x
ROA 262.73%
Debt
50 /100
Moderate Current ratio 0.25x
Net debt/EBITDA 0.15x
Int. coverage -6.23x
Stability
37 /100
Moderate Beta 0.74x
Profitable years 0
EPS volatility 285.51%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about CGNSF
Online
Sector
Healthcare
Industry
Medical - Healthcare Information Services
CEO
Sina Habibi
Employees
2,500
Headquarters
Vancouver
Upcoming events
05 OCT
Earnings
Upcoming earnings report